DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

0.00 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

FRX $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS $3.78

Sector

Healthcare

Industry

Drug Makers

Forest Laboratories, Inc. (FRX) Description

The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. Website: http://www.frx.com/

News & Commentary Rss Feed

Can This Pharma Go From Good to Great?

Will Actavis' $66 billion merger with Allergan catapult this company from good to great? Or could a hidden risk derail this global powerhouse?

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Bill Nygren's Fourth Quarter Commentary - Oakmark Fund

Actavis shares outpace buyout target’s gains

Pfizer held takeover talks with Actavis

Today In SA PRO: Wednesday, September 10

Today In SA PRO: Tuesday, September 9

Today In SA PRO: Monday, September 8

This Week's Outstanding Performance Winners - Jason Radin (Short Fairway) And Buddy Lyons (Long Fore

This Week's Outstanding Performance Winners - Jason Radin (Short Fairway) And Buddy Lyons (Long Forest Labs)

See More FRX News...

FRX's Top Competitors

FRX $0.00 (0.00%)
Current stock: FRX
RHHBY $36.83 (-0.94%)
Current stock: RHHBY
JNJ $101.35 (-1.04%)
Current stock: JNJ
PFE $34.28 (-0.23%)
Current stock: PFE